PMID: 6110217Jan 1, 1980Paper

Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia

Psychopharmacology
B AngristS Gershon

Abstract

Positive symptoms of schizophrenia were diminished by neuroleptics and increased by amphetamine and accounted for most of the change seen in the total Brief Psychiatric Rating Scale (BPRS). Negative symptoms in the same subjects were not affected by neuroleptics but increased after amphetamines to a degree that just attained statistical significance. This increase was due to one item (emotional withdrawal) of the negative symptom factor which responded to neuroleptics and amphetamines as did positive symptoms. These findings are discussed with respect to new ideas about the role of dopamine in schizophrenia.

References

Jun 1, 1978·Archives of General Psychiatry·R L SpitzerE Robins
Apr 1, 1978·Acta Psychiatrica Scandinavica·E C JohnstoneJ Husband
Jan 1, 1976·Schizophrenia Bulletin·H Y Meltzer, S M Stahl
Jan 12, 1980·British Medical Journal·T J Crow

❮ Previous
Next ❯

Citations

Jan 1, 1987·Psychopharmacology·J A LiebermanJ Alvir
Jan 1, 1984·European Archives of Psychiatry and Neurological Sciences·P LinkowskiJ Mendlewicz
Jan 1, 1985·Psychopharmacology·B AngristJ Rotrosen
Jan 1, 1982·Psychopharmacology·B AngristJ Rotrosen
Feb 1, 1992·Community Mental Health Journal·C A HalterR De Graaf-Kaser
Jan 1, 1989·The Psychiatric Quarterly·S J Bartels, R E Drake
Jan 1, 1993·Journal of Neural Transmission. General Section·A A Grace
Jan 1, 1989·European Archives of Psychiatry and Neurological Sciences·W Gaebel
Nov 15, 1982·Experientia·T J Crow
Jun 10, 2009·Neuropsychology Review·Philip D Harvey
Aug 15, 1994·Biological Psychiatry·J M PrietoN Caycedo
Jan 1, 1994·Comprehensive Psychiatry·L A OplerP M Ramirez
Jan 1, 1986·Journal of Psychiatric Research·M DavidsonK L Davis
Jan 1, 1995·Life Sciences·C J SchmidtM G Palfreyman
Jan 1, 1983·Neuroscience and Biobehavioral Reviews·J N Joyce
Jan 1, 1994·Neuroscience and Biobehavioral Reviews·J L Cadet, L A Kahler
Sep 1, 1985·Psychiatry Research·A C IagerR J Wyatt
Jan 1, 1987·Psychiatry Research·S ThiemannP A Berger
Mar 1, 1990·Psychiatry Research·J W NewcomerJ G Csernansky
Aug 30, 1996·Psychiatry Research·D P van KammenM Sato
Jul 1, 1992·Progress in Neuro-psychopharmacology & Biological Psychiatry·Y MizukiM Yamada
Jan 1, 1992·Progress in Neuro-psychopharmacology & Biological Psychiatry·M R Lynch
Jan 1, 1994·Brain Research Bulletin·K YamamotoM Yoshii
Jan 1, 1987·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·R M Bilder, E Goldberg
Mar 1, 1990·Schizophrenia Research·P Kulhara, K Chandiramani
Mar 1, 1993·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·H J Möller

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here